Nivolumab and rituximab in treatment naive follicular lymphoma: the phase II '1st FLOR' study.
Barraclough A, Lee ST, Burgess M, Churilov L, Chong G, Lee D, Gilbertson M, Fancourt T, Manos K, Ritchie D, Koldej RM, Scott A, Keane C, Hawkes EA.
Barraclough A, et al. Among authors: lee d.
Blood Adv. 2025 Jan 24:bloodadvances.2024015487. doi: 10.1182/bloodadvances.2024015487. Online ahead of print.
Blood Adv. 2025.
PMID: 39853272